Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 4 Trials for Dexamethasone (DB01234)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting4 IdentifierTitlePurposeDrugs
NCT03432949Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPCTreatment